QVIDTVM Management LLC
Net seller this quarter
$76.6M
14
-$21.6M
99.2%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 BIO | $19.4M | 25.39% | 0.24% | -20.9% | Q3 2023 |
 NBIS | $13.4M | 17.54% | 0.02% | -19.8% | Q4 2025 |
 AMRZ | $13.2M | 17.21% | 0.05% | +13.8% | Q4 2025 |
 ORCL | $8.35M | 10.90% | 0.00% | +46.4% | Q1 2026 |
 SOLV | $6.87M | 8.97% | 0.05% | -66.5% | Q1 2024 |
 ZGN | $5.93M | 7.75% | 0.19% | -13.3% | Q3 2024 |
 ARE | $4.36M | 5.69% | 0.05% | +106.2% | Q4 2025 |
 BRCC | $3.28M | 4.28% | 3187.10% | -13.2% | Q1 2023 |
 OCTV | $937K | 1.22% | Not reported | New | Q2 2026 |
 WAB | $202K | 0.26% | 0.00% | -72.9% | Q3 2022 |
 XRAY | $201K | 0.26% | 0.01% | -95.1% | Q1 2024 |
 PM | $186K | 0.24% | 0.00% | -4.9% | Q1 2026 |
 LAB | $183K | 0.24% | 0.06% | -3.2% | Q4 2025 |
 HRB | $32.1K | 0.04% | 0.00% | -96.4% | Q1 2026 |
| Q1 2026 | |||||
| BIO | $23.3M | 28.68% | 0.30% | +0.3% | Q3 2023 |
| SOLV | $17.3M | 21.32% | 0.15% | -8.6% | Q1 2024 |
| AMRZ | $12.2M | 14.97% | 0.04% | +0.4% | Q4 2025 |
| NBIS | $6.3M | 7.74% | 0.02% | +74.9% | Q4 2025 |
| ORCL | $5.72M | 7.03% | 0.00% | New | Q1 2026 |
| ZGN | $5.48M | 6.73% | 0.22% | +10.5% | Q3 2024 |
| XRAY | $4.47M | 5.49% | 0.19% | -20.6% | Q1 2024 |
| BRCC | $2.64M | 3.24% | 3670.10% | Not reported | Q1 2023 |
| ARE | $1.86M | 2.28% | 0.02% | Not reported | Q4 2025 |
| HRB | $738K | 0.91% | 0.02% | New | Q1 2026 |
| WAB | $692K | 0.85% | 0.00% | -18.6% | Q3 2022 |
 RTO | $217K | 0.27% | 0.00% | Not reported | Q4 2022 |
| LAB | $211K | 0.26% | 0.06% | Not reported | Q4 2025 |
| PM | $178K | 0.22% | 0.00% | New | Q1 2026 |
| Q4 2025 | |||||
| BIO | $25.3M | 28.62% | 0.30% | -34.0% | Q3 2023 |
| SOLV | $23M | 26.06% | 0.17% | -41.5% | Q1 2024 |
| AMRZ | $11.7M | 13.25% | 0.04% | New | Q4 2025 |
| XRAY | $5.55M | 6.28% | 0.24% | -2.0% | Q1 2024 |
| ZGN | $4.88M | 5.52% | 0.20% | +33892.4% | Q3 2024 |
 COTY | $4.67M | 5.28% | 0.17% | -5.9% | Q1 2025 |
| BRCC | $3.77M | 4.27% | 3670.10% | +1.8% | Q1 2023 |
 EQIX | $3.39M | 3.84% | 0.00% | New | Q4 2025 |
| NBIS | $2.9M | 3.29% | 0.01% | New | Q4 2025 |
| ARE | $1.96M | 2.21% | 0.02% | New | Q4 2025 |
| WAB | $727K | 0.82% | 0.00% | -64.6% | Q3 2022 |
| LAB | $294K | 0.33% | 0.06% | New | Q4 2025 |
| RTO | $203K | 0.23% | 0.00% | -99.6% | Q4 2022 |
| Q3 2025 | |||||
| SOLV | $36.3M | 39.02% | 0.29% | -3.3% | Q1 2024 |
| BIO | $35.5M | 38.17% | 0.46% | +0.3% | Q3 2023 |
| COTY | $6.51M | 7.00% | 0.18% | +0.4% | Q1 2025 |
| XRAY | $6.28M | 6.76% | 0.25% | +6.8% | Q1 2024 |
| BRCC | $5.21M | 5.61% | 3605.35% | +1.2% | Q1 2023 |
| WAB | $1.93M | 2.07% | 0.01% | -13.5% | Q3 2022 |
| ZGN | $1.1M | 1.18% | 0.00% | -99.7% | Q3 2024 |
| RTO | $169K | 0.18% | 0.07% | +669.1% | Q4 2022 |